A Comparison of the Adverse Effects and Utility of Different Monoclonal Antibodies for SARS-CoV-2: A Retrospective Cohort Study.

REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche

bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly

bamlanivimab/etesevimab (LY-CoV555/LY-CoV016) - Eli Lilly

Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases

http://www.ncbi.nlm.nih.gov/pubmed/37680398

Brandon W Knopp; Evan Goldstein; Hannah Z Weiss; Jeniel Parmar; Samer Fahmy

Sep 9, 2023